Respiratory Motion, Inc., Receives 510(k) Clearance for ExSpiron™ Monitor

Waltham, Mass. – October 10, 2012 – Respiratory Motion, Inc. today announced 510(k) clearance from the US Food and Drug Administration (FDA) for its ExSpiron respiratory monitoring system, the first to provide continuous, noninvasive Minute Ventilation data in nonventilated patients. A presentation on the technology will be given at the American Society of Anesthesiologists (ASA) annual conference on October 16.   

Minute Ventilation data (the amount of air that enters/leaves the lungs every minute) – along with ExSpiron’s other respiratory data – are quantitative measures of breathing that have not been previously available to physicians across the continuum of care.   

Read the full press release here.

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out